The purpose of the Clinical Data and Data Management Core (CDDM) is to support the clinical data requirements of current and future SPORE projects. Three distinct requirements activities are encompassed within this core: (1) data management for clinical trials conducted through the SPORE; (2) collection of clinical data on patients with breast cancer receiving their care within SPORE institutions; and (3) maintenance of the database storing information; and (3) maintenance of the database storing information on specimens processed by the Tissue and Pathology Core. Many of the SPORE projects will require the services provided by the CDDM Core. For projects involving a clinical trial, data managers of the CDDM will perform all tasks related to completion of study forms for trial participants. The Clinical Research Information system (CRIS) a multi- institutional relational clinical database will support SPORE activities in threeways. First survey data from patients will help identify families for possible inclusion in the High-Risk Patients and Families core, or subjects eligible for specific studies. Second, CRIS data linked to specimens will allow for correlations between specific laboratory finding sand clinical outcomes. Third, CRIS will serve as the database for selected observational studies. The Specimen Tracking Information Program (STIP) will support the handling of patient specimens for a number of SPORE projects, and is instrumental in constructing the multi-institutional virtual SPORE specimen bank. The activities of the CDDM Core will facilitate current and future translational research studies. Working together, the HRPF, TP, and CDDM Cores will generate a very large bank of specimens linked to comprehensive coded clinical data on risk factors, stage at diagnosis, response to therapy, complications, and survival. Studies using this resource to examine the relationship between established and experimental laboratory assays and risk factors/outcomes have the potential to make important contributions to our understanding of the etiology, prevention, and treatment of breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA089393-01
Application #
6402290
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2000-09-30
Project End
2005-09-29
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Kabraji, Sheheryar; Ni, Jing; Lin, Nancy U et al. (2018) Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain? Clin Cancer Res 24:1795-1804
Punglia, Rinaa S; Jiang, Wei; Lipsitz, Stuart R et al. (2018) Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat 167:751-759
Liu, Hui; Murphy, Charles J; Karreth, Florian A et al. (2018) Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer. Cancer Discov 8:354-369
Asdourian, Maria S; Swaroop, Meyha N; Sayegh, Hoda E et al. (2017) Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery. J Clin Oncol 35:3934-3941
Sun, Fangdi; Skolny, Melissa N; Swaroop, Meyha N et al. (2016) The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema. Breast Cancer Res Treat 157:229-240
Ferguson, Chantal M; Swaroop, Meyha N; Horick, Nora et al. (2016) Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer. J Clin Oncol 34:691-8
Miller, Cynthia L; Colwell, Amy S; Horick, Nora et al. (2016) Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study. Ann Surg 263:399-405
Sherr, Charles J; Beach, David; Shapiro, Geoffrey I (2016) Targeting CDK4 and CDK6: From Discovery to Therapy. Cancer Discov 6:353-67
Asdourian, Maria S; Skolny, Melissa N; Brunelle, Cheryl et al. (2016) Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. Lancet Oncol 17:e392-405
Kochupurakkal, Bose S; Iglehart, J Dirk (2016) Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA. Genom Data 7:92-3

Showing the most recent 10 out of 291 publications